Recent studies reveal that prostate cancer harbors a distinct microbiome enriched in Gram-negative Proteobacteria, suggesting a tumor microenvironment populated with bacterial ligands capable of activating TLR4 (25). This evidence concerns the gene TLR4 and prostate carcinoma.